Lotus Net Receivables from 2010 to 2024

600186 Stock   5.30  0.05  0.95%   
Lotus Health's Net Receivables is decreasing over the years with slightly volatile fluctuation. Net Receivables is expected to dwindle to about 98.3 M. From 2010 to 2024 Lotus Health Net Receivables quarterly data regression line had arithmetic mean of  388,857,098 and r-squared of  0.82. View All Fundamentals
 
Net Receivables  
First Reported
2000-06-30
Previous Quarter
104 M
Current Value
145.6 M
Quarterly Volatility
576.4 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Lotus Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Lotus Health's main balance sheet or income statement drivers, such as Interest Expense of 534.9 K, Selling General Administrative of 145.4 M or Total Revenue of 2 B, as well as many indicators such as . Lotus financial statements analysis is a perfect complement when working with Lotus Health Valuation or Volatility modules.
  
This module can also supplement various Lotus Health Technical models . Check out the analysis of Lotus Health Correlation against competitors.

Currently Active Assets on Macroaxis

Other Information on Investing in Lotus Stock

Lotus Health financial ratios help investors to determine whether Lotus Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Lotus with respect to the benefits of owning Lotus Health security.